08:21 AM EDT, 05/05/2025 (MT Newswires) -- Microbix Biosystems ( MBXBF ) , a life sciences innovator, manufacturer, and exporter, that saw its shares rise more than 8% last Friday, announced Monday that its funding and commercialization partner, Sequel Pharma, LLC, has executed an agreement with an international contract development and manufacturing organization for production of the formulated and packaged drug Kinlytic, a biologic drug for dissolving blood clots.